Health Care · Rockville, MDNewNo press found
Kaigene, Inc.
Kaigene, Inc. is a biotechnology company based in Rockville, Maryland. In a Form D filed with the SEC on October 14, 2026, it reported raising $54,958,229 from 22 investors as part of an offering of up to $73,350,000. The first sale in the offering took place on September 30, 2026.
No press found. No news article or press release about this raise turned up when we searched on October 15, 2026. Announcements sometimes come weeks after a filing, so we check again. More raises with no press found
- 2nd Form D since 2022. Earlier new notices: Mar 29, 2022. All filings on EDGAR
- Still raising. $18.4M of the $73.3M offering was still unsold at filing.
$56.3M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Mar 29, 2022. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 14, 2026 | $55M | $73.3M | 22 |
| Mar 29, 2022 | $1.4M | $5M | 3 |
Filing details
- Amount raised
- $54,958,229
- Offering size
- $73,350,000
- Investors so far
- 22
- First sale
- September 30, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Rockville, Maryland
- Incorporated
- Delaware, 2021
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $54,958,229 | $73,350,000 | 22 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Similar raises
ColoWatch, Inc. /MD/
Gaithersburg, MD · filed Oct 8First Form DStill raising
Templar Nova, Inc.
Rockville, MD · filed Oct 7First Form D
Monocacy Therapeutics Inc.
Monrovia, MD · filed Oct 75th Form D since 2026
Seraxis Holdings, Inc.
Germantown, MD · filed Sep 24Seraxis is a private biotechnology company that has developed a novel cell and immune-evasion technology with the goal to reverse Type 1 Diabetes.
2nd Form D since 2021